Baseline characteristics for patients with metastatic renal cell carcinoma receiving first-line tyrosine kinase inhibitors or immune checkpoint inhibitors.
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://figshare.com/articles/dataset/Baseline_characteristics_for_patients_with_metastatic_renal_cell_carcinoma_receiving_first-line_tyrosine_kinase_inhibitors_or_immune_checkpoint_inhibitors_/25502712
下载链接
链接失效反馈官方服务：
资源简介：
Baseline characteristics for patients with metastatic renal cell carcinoma receiving first-line tyrosine kinase inhibitors or immune checkpoint inhibitors.
创建时间：
2024-03-28
